Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Federal Trade Commission
Harvard Business School
Merck
Chinese Patent Office
Johnson and Johnson
Deloitte
Farmers Insurance
Chubb

Generated: September 20, 2018

DrugPatentWatch Database Preview

Cycloserine - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for cycloserine and what is the scope of cycloserine patent protection?

Cycloserine is the generic ingredient in one branded drug marketed by Purdue Gmp and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for cycloserine. Two suppliers are listed for this compound.

Medical Subject Heading (MeSH) Categories for cycloserine
Synonyms for cycloserine
.alpha.-Cycloserine
(+)-4-Amino-3-isoxazolidinone
(+)-Cycloserine
(4R)-4-amino-1,2-oxazolidin-3-one
(4R)-4-amino-2,4,5-trihydroisoxazol-3-one
(4R)-4-Amino-3-isoxazolidinone
(4R)-4-aminoisoxazolidin-3-one
(R)-(+)-4-Amino-3-isoxazolidinone
(R)-(+)-Cycloserine
(R)-3-Isoxazolidinone, 4-amino-
(R)-4-amino-1,2-oxazolidin-3-one
(R)-4-Amino-3-isoxazolidinone
(R)-4-Amino-3-isoxazolidone
(R)-4-AMINO-ISOXAZOLIDIN-3-ONE
(R)-4-AMINOISOXAZOLIDIN-3-ONE
(R)-Cycloserine
(S)-(-)-Cycloserine
005C353
101039-EP2295402A2
101039-EP2301544A1
1pb9
3-Isoxazolidinone, 4-amino-, (+)-
3-Isoxazolidinone, 4-amino-, (+)- (8CI)
3-Isoxazolidinone, 4-amino-, (+)-(8CI)
3-Isoxazolidinone, 4-amino-, (4R)-
3-Isoxazolidinone, 4-amino-, (4R)- (9CI)
3-isoxazolidinone, 4-amino-, (4r)-(9ci)
3-Isoxazolidinone, 4-amino-, (R)
3-Isoxazolidinone, 4-amino-, (R)-
3-Isoxazolidinone, 4-amino-, D
3-Isoxazolidinone, 4-amino-, d-
4-27-00-05549 (Beilstein Handbook Reference)
4-Amino-3-isoxazolidinone, (R)-
4-Amino-3-isoxazolidinone, D-
4-Amino-isoxazolidin-3-one
4-Isoxazolidinamine, 3-oxo-, (D)-
4AX
68-41-7
95IK5KI84Z
AB0007232
AB00443920
AB00443920_09
AB00443920_10
AB2000415
AC-4721
AC1L1M33
AC1Q4UA7
ACT04767
AI3-50153
AJ-89953
AK-26256
AKOS015994626
alpha-Cycloserine
AN-11678
BB_NC-1631
BDBM50038178
BDBM50103516
BIDD:GT0707
BPBio1_001252
BR-26256
BRN 0080798
BSPBio_001138
BSPBio_002121
C 3909
C-9390
C-9400
C08057
CAS-339-72-0
CAS-68-41-7
CCG-39705
CHEBI:40009
CHEMBL771
Cicloserina
Cicloserina [INN-Spanish]
Cicloserina [Italian]
Closerin
Closina
CPD000058313
CS-2395
Cyclo-D-serine
Cyclorin
Cycloserin
CYCLOSERINE (D)
Cycloserine (JP15/USP/INN)
Cycloserine (JP17/USP/INN)
Cycloserine [INN:BAN:JAN]
Cycloserine [USP:INN:BAN:JAN]
Cycloserine, D-
Cycloserine, Pharmaceutical Secondary Standard; Certified Reference Material
Cycloserine, United States Pharmacopeia (USP) Reference Standard
Cycloserinum
Cycloserinum [INN-Latin]
D-(+)-Cycloserine
D-4-Amino-3-isossazolidone
D-4-Amino-3-isossazolidone [Italian]
D-4-amino-3-isoxazolidinone
D-4-amino-3-isoxazolidone
D-amino-3-isoxazolidinone
D-CS
D-cycloserine
D-Cycloserine synth. BP 88
D-Cycloserine, >=96.0% (NT)
D-Cycloserine, powder
D-Cycloserine, synthetic
D-Oxamicina
D-Oxamycin
D00877
D02WFK
D04TMQ
D0G6RT
DB00260
DivK1c_000098
DRG-0195
DSSTox_CID_2870
DSSTox_GSID_22870
DSSTox_RID_76766
DTXSID8022870
DYDCUQKUCUHJBH-UWTATZPHSA-N
E-733-A
EINECS 200-688-4
EU-0100252
F2173-1228
FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09
Farmiserina
FC1270
FT-0624464
GTPL9489
HE336467
HMS1571I20
HMS1920C06
HMS2051C15
HMS2091I14
HMS2098I20
HMS2232F03
HMS3259L19
HMS3260D06
HMS500E20
HS-0079
HSDB 3218
HY-B0030
I-1431
IDI1_000098
K-300
K138
KB-49618
KBio1_000098
KBio2_001340
KBio2_003908
KBio2_006476
KBio3_001341
KBioGR_000890
KBioSS_001340
KS-00001FB7
LMPK14000007
Lopac-C-1159
Lopac-C-3909
Lopac-C-7005
Lopac0_000252
LP00252
LS-86757
MCULE-4212827696
MFCD00005353
Micoserina
Miroserina
Miroseryn
MLS000758215
MLS001423962
MLS002548887
MolPort-000-858-643
NC00050
NC00676
NCGC00015213-01
NCGC00015213-02
NCGC00015213-03
NCGC00016306-01
NCGC00016306-02
NCGC00016306-03
NCGC00016306-04
NCGC00016306-05
NCGC00016306-07
NCGC00016306-08
NCGC00093713-01
NCGC00093713-02
NCGC00260937-01
NINDS_000098
NJ-21
Novoserin
NSC 154851
NSC-756712
NSC756712
orientomycin
Oxamicina
Oxamicina [Italian]
Oxamycin
PA 94
PA-94
Pharmakon1600-01500215
Prestwick0_001089
Prestwick1_001089
Prestwick2_001089
Prestwick3_001089
PubChem5763
R (+)-4-amino-3-isoxazolidinone
R-(+)-Cycloserine
R-4-Amino-3-isoxazolidinone
R(+)-4-Amino-3-isoxazolidinone
RL04615
RO-1-9213
s1998
SAM001247014
SAM002264599
SBI-0050240.P004
SC-06256
SC-49088
SCHEMBL34322
Serine, cyclo-
Seromycin
Seromycin (TN)
SMP1_000167
SMR000058313
SPBio_000008
SPBio_003029
Spectrum_000860
SPECTRUM1500215
Spectrum2_000084
Spectrum3_000371
Spectrum4_000305
Spectrum5_000797
SR-01000075432
SR-01000075432-1
ST075697
ST2408171
Tebemicina
Tisomycin
Tox21_110361
Tox21_110361_1
Tox21_500252
UNII-95IK5KI84Z
Wasserina
Z1522567171
ZINC34676245

US Patents and Regulatory Information for cycloserine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purdue Gmp SEROMYCIN cycloserine CAPSULE;ORAL 060593-001 Approved Prior to Jan 1, 1982 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Federal Trade Commission
Harvard Business School
Merck
Chinese Patent Office
Johnson and Johnson
Deloitte
Farmers Insurance
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.